72 related articles for article (PubMed ID: 10445845)
21. The phosphatidylinositol 3' kinase pathway is required for the survival signal of leukocyte tyrosine kinase.
Ueno H; Honda H; Nakamoto T; Yamagata T; Sasaki K; Miyagawa K; Mitani K; Yazaki Y; Hirai H
Oncogene; 1997 Jun; 14(25):3067-72. PubMed ID: 9223670
[TBL] [Abstract][Full Text] [Related]
22. TNNI3K, a cardiac-specific kinase, promotes physiological cardiac hypertrophy in transgenic mice.
Wang X; Wang J; Su M; Wang C; Chen J; Wang H; Song L; Zou Y; Zhang L; Zhang Y; Hui R
PLoS One; 2013; 8(3):e58570. PubMed ID: 23472207
[TBL] [Abstract][Full Text] [Related]
23. Transgenic overexpression of USP15 in the heart induces cardiac remodeling in mice.
Isumi Y; Hirata T; Saitoh H; Miyakawa T; Murakami K; Kudoh G; Doi H; Ishibashi K; Nakajima H
Biochem Biophys Res Commun; 2011 Feb; 405(2):216-21. PubMed ID: 21219870
[TBL] [Abstract][Full Text] [Related]
24. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium.
Kolodziejczyk SM; Wang L; Balazsi K; DeRepentigny Y; Kothary R; Megeney LA
Curr Biol; 1999 Oct; 9(20):1203-6. PubMed ID: 10531040
[TBL] [Abstract][Full Text] [Related]
25. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
26. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
[TBL] [Abstract][Full Text] [Related]
27. Four tissue-specific mouse ltk mRNAs predict tyrosine kinases that differ upstream of their transmembrane segment.
Snijders AJ; Haase VH; Bernards A
Oncogene; 1993 Jan; 8(1):27-35. PubMed ID: 8380920
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
[TBL] [Abstract][Full Text] [Related]
29. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice.
Gruver CL; DeMayo F; Goldstein MA; Means AR
Endocrinology; 1993 Jul; 133(1):376-88. PubMed ID: 8319584
[TBL] [Abstract][Full Text] [Related]
30. Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice.
Wakui H; Tamura K; Tanaka Y; Matsuda M; Bai Y; Dejima T; Masuda S; Shigenaga A; Maeda A; Mogi M; Ichihara N; Kobayashi Y; Hirawa N; Ishigami T; Toya Y; Yabana M; Horiuchi M; Minamisawa S; Umemura S
Hypertension; 2010 May; 55(5):1157-64. PubMed ID: 20231526
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
32. Cyclin-dependent kinase-9: an RNAPII kinase at the nexus of cardiac growth and death cascades.
Sano M; Schneider MD
Circ Res; 2004 Oct; 95(9):867-76. PubMed ID: 15514168
[TBL] [Abstract][Full Text] [Related]
33. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice.
Zhang D; Gaussin V; Taffet GE; Belaguli NS; Yamada M; Schwartz RJ; Michael LH; Overbeek PA; Schneider MD
Nat Med; 2000 May; 6(5):556-63. PubMed ID: 10802712
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase D in the hypertrophy pathway.
Sin YY; Baillie GS
Biochem Soc Trans; 2012 Feb; 40(1):287-9. PubMed ID: 22260707
[TBL] [Abstract][Full Text] [Related]
36. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
Gilsbach R; Schneider J; Lother A; Schickinger S; Leemhuis J; Hein L
Cardiovasc Res; 2010 Jun; 86(3):432-42. PubMed ID: 20083574
[TBL] [Abstract][Full Text] [Related]
37. A lymphocyte-specific Ltk tyrosine kinase isoform is retained in the endoplasmic reticulum in association with calnexin.
Snijders AJ; Ho SC; Haase VH; Pillai S; Bernards A
J Biol Chem; 1997 Jan; 272(2):1297-301. PubMed ID: 8995435
[TBL] [Abstract][Full Text] [Related]
38. Morphometry and muscle gene expression in hypertrophied hearts from polyomavirus large T antigen transgenic mice.
Holder E; Mitmaker B; Alpert L; Chalifour L
Am J Physiol; 1995 Jul; 269(1 Pt 2):H86-95. PubMed ID: 7631879
[TBL] [Abstract][Full Text] [Related]
39. ALK-activating homologous mutations in LTK induce cellular transformation.
Roll JD; Reuther GW
PLoS One; 2012; 7(2):e31733. PubMed ID: 22347506
[TBL] [Abstract][Full Text] [Related]
40. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum.
Bauskin AR; Alkalay I; Ben-Neriah Y
Cell; 1991 Aug; 66(4):685-96. PubMed ID: 1652370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
